The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Peter Laszlo Lakatos

1st Department of Medicine

Semmelweis University

Budapest

Hungary

[email]@*.sote.hu

Name/email consistency: medium

 
 
 
 
 
 
 

Affiliations

  • 1st Department of Medicine, Semmelweis University, Budapest, Hungary. 2002 - 2011
  • Semmelweis University, First Department of Medicine, H1083 Budapest, Koranyi S 2A, Hungary. 2008

References

  1. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008. Lakatos, P.L., David, G., Pandur, T., Erdelyi, Z., Mester, G., Balogh, M., Szipocs, I., Molnar, C., Komaromi, E., Kiss, L.S., Lakatos, L. J. Crohns. Colitis (2011) [Pubmed]
  2. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease. Lakatos, P.L., Kiss, L.S., Palatka, K., Altorjay, I., Antal-Szalmas, P., Palyu, E., Udvardy, M., Molnar, T., Farkas, K., Veres, G., Harsfalvi, J., Papp, J., Papp, M. Inflamm. Bowel Dis. (2011) [Pubmed]
  3. IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008. Lakatos, P.L., David, G., Pandur, T., Erdelyi, Z., Mester, G., Balogh, M., Szipocs, I., Molnar, C., Komaromi, E., Kiss, L.S., Lakatos, L. J. Crohns. Colitis (2011) [Pubmed]
  4. Double-balloon endoscopy for small intestinal disease: a single-center experience in Hungary. Lakatos, P.L., Horvath, H.C., Zubek, L., Pak, G., Pak, P., Fuszek, P., Nagypal, A., Papp, J. Med. Sci. Monit. (2010) [Pubmed]
  5. Is there an increased risk of lymphoma and malignancies under anti-TNF therapy in IBD? Lakatos, P.L., Miheller, P. Curr. Drug. Targets (2010) [Pubmed]
  6. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease. Lakatos, P.L., Czegledi, Z., David, G., Kispal, Z., Kiss, L.S., Palatka, K., Kristof, T., Nagy, F., Salamon, A., Demeter, P., Miheller, P., Szamosi, T., Banai, J., Papp, M., Bene, L., Kovacs, A., Racz, I., Lakatos, L. J. Crohns. Colitis (2010) [Pubmed]
  7. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. Lakatos, P.L., Czegledi, Z., Szamosi, T., Banai, J., David, G., Zsigmond, F., Pandur, T., Erdelyi, Z., Gemela, O., Papp, J., Lakatos, L. World J. Gastroenterol. (2009) [Pubmed]
  8. Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort. Lakatos, P.L., Altorjay, I., Szamosi, T., Palatka, K., Vitalis, Z., Tumpek, J., Sipka, S., Udvardy, M., Dinya, T., Lakatos, L., Kovacs, A., Molnar, T., Tulassay, Z., Miheller, P., Barta, Z., Stocker, W., Papp, J., Veres, G., Papp, M. Inflamm. Bowel Dis. (2009) [Pubmed]
  9. Is there a benefit from the concomitant use of immunosupression with anti-TNF in Crohn's disease; heads or tails? Lakatos, P.L. Rev. Recent. Clin. Trials (2009) [Pubmed]
  10. Environmental factors affecting inflammatory bowel disease: have we made progress?. Lakatos, P.L. Dig. Dis (2009) [Pubmed]
  11. Is There an Increased Risk of Lymphoma and Malignancies Under Anti-TNF Therapy in IBD?. Lakatos, P.L., Miheller, P. Curr. Drug. Targets (2009) [Pubmed]
  12. Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet? Lakatos, P.L., Lakatos, L. Pharmacol. Res. (2008) [Pubmed]
  13. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins? Lakatos, P.L., Altorjay, I., Mándi, Y., Lakatos, L., Tumpek, J., Kovacs, A., Molnar, T., Tulassay, Z., Miheller, P., Palatka, K., Szamosi, T., Fischer, S., Papp, J., Papp, M. Tissue. Antigens (2008) [Pubmed]
  14. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Lakatos, P.L., Szamosi, T., Szilvasi, A., Molnar, E., Lakatos, L., Kovacs, A., Molnar, T., Altorjay, I., Papp, M., Tulassay, Z., Miheller, P., Papp, J., Tordai, A., Andrikovics, H. Dig. Liver. Dis (2008) [Pubmed]
  15. Double-balloon enteroscopy for the diagnosis and treatment of obscure bleeding, inflammatory bowel diseases and polyposis syndromes: we see more but do we know more? Lakatos, P.L., Fuszek, P., Horvath, H.C., Zubek, L., Haller, P., Papp, J. Hepatogastroenterology (2008) [Pubmed]
  16. Ulcerative proctitis: a review of pharmacotherapy and management. Lakatos, P.L., Lakatos, L. Expert. Opin. Pharmacother (2008) [Pubmed]
  17. DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease. Lakatos, P.L., Fischer, S., Claes, K., Kovacs, A., Molnar, T., Altorjay, I., Demeter, P., Tulassay, Z., Palatka, K., Papp, M., Rutgeerts, P., Szalay, F., Papp, J., Vermeire, S., Lakatos, L. Inflamm. Bowel Dis. (2006) [Pubmed]
  18. Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature. Lakatos, P.L., Fekete, S., Horanyi, M., Fischer, S., Abonyi, M.E. World J. Gastroenterol. (2006) [Pubmed]
  19. Recent trends in the epidemiology of inflammatory bowel diseases: up or down?. Lakatos, P.L. World J. Gastroenterol. (2006) [Pubmed]
  20. Mucocele of the appendix: an unusual cause of lower abdominal pain in a patient with ulcerative colitis. A case report and review of literature. Lakatos, P.L., Gyori, G., Halasz, J., Fuszek, P., Papp, J., Jaray, B., Lukovich, P., Lakatos, L. World J. Gastroenterol. (2005) [Pubmed]
  21. Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. Lakatos, P.L., Lakatos, L., Szalay, F., Willheim-Polli, C., Osterreicher, C., Tulassay, Z., Molnar, T., Reinisch, W., Papp, J., Mozsik, G., Ferenci, P. World J. Gastroenterol. (2005) [Pubmed]
  22. Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery. Lakatos, P.L., Szalay, F., Tulassay, Z., Molnar, T., Kovacs, A., Gasztonyi, B., Papp, J., Lakatos, L. Hepatogastroenterology (2005) [Pubmed]
  23. Insulin-like growth factor I gene microsatellite repeat, collagen type Ialpha1 gene Sp1 polymorphism, and bone disease in primary biliary cirrhosis. Lakatos, P.L., Bajnok, E., Tornai, I., Folhoffer, A., Horvath, A., Lakatos, P., Habior, A., Szalay, F. Eur. J. Gastroenterol. Hepatol (2004) [Pubmed]
  24. Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Lakatos, L.P., Bajnok, E., Hegedus, D., Tóth, T., Lakatos, P., Szalay, F. Eur. J. Gastroenterol. Hepatol (2002) [Pubmed]
 
WikiGenes - Universities